Omrix Biopharmaceuticals Company Profile

09:51 EDT 18th March 2018 | BioPortfolio

We aim to develop novel technologies to provide safer and more effective options to patients in areas with substantial unmet medical needs, particularly in the areas of biosurgical and passive immunotherapy products. We are utilizing our proprietary protein purification technology, innovative development capabilities, and manufacturing know-how to develop these product lines, often through collaborations with companies whose marketing and sales expertise are a complement to our own areas of specialty. Our biosurgical product line includes products and product candidates that are used for the control of bleeding, or hemostasis, and other surgical applications. We compete in the active biosurgical hemostats market, which we believe is the fastest growing segment of the surgical sealant market. We are currently partnered with Ethicon Inc., a Johnson & Johnson Company, in the development of unique biosurgical devices which will meet critical unmet medical needs. Our passive immunotherapy product line includes antibody-rich products and product candidates for the treatment of immune deficiencies and infectious diseases and for potential biodefense applications. We supply vaccinia immunoglobulin, or VIG, to several governments as a means to treat smallpox vaccine-related complications in the event of a smallpox terrorist attack . We currently market in Israel intravenous immunoglobulin, or IVIG, an antibody-based product used to treat primary immune deficiencies, as well as enriched hepatitis B immune globulin (HBIG), and we are broadening our passive immunotherapy platform by improving our current products and developing new product candidates.


630 5th Avenue, 22nd Floor
New York
New York
United States of America


Phone: 212 887 6500
Fax: 212 887 6550

News Articles [143 Associated News Articles listed on BioPortfolio]

-$0.19 EPS Expected for Keryx Biopharmaceuticals (KERX) This Quarter

Equities analysts predict that Keryx Biopharmaceuticals will announce earnings per share of for the current fiscal quarter, Zacks reports. Three analysts have issued estimates for Keryx Biopharmaceuti...

$18.60 Million in Sales Expected for Keryx Biopharmaceuticals (KERX) This Quarter

Wall Street brokerages predict that Keryx Biopharmaceuticals will post sales of $18.60 million for the current fiscal quarter, Zacks Investment Research reports. Three analysts have issued estimates f...

Sienna Biopharmaceuticals nets $69.5mm in Nasdaq IPO

Aesthetics- and dermatology-focused Sienna Biopharmaceuticals Inc. (targeted topical delivery technology) netted $69.5mm through an initial public offering of 4.9mm shares (including the overallotment...

New international partnership promises great potential for next-generation biopharmaceuticals

There are a multitude of challenges associated with the production of next-generation biopharmaceuticals and vaccines. The Austrian Centre of Industrial Biotechnology and the BOKU - University of Natu...

Global and Chinese Biopharmaceuticals Industry, 2017 Market Research Report [Report Updated: 29122017] Prices from USD $3000

The 'Global and Chinese Biopharmaceuticals Industry, 20122022 Market Research Report' is a professional and indepth study on the current state of the global Biopharmaceuticals industry with a focus on...

Apotex And Intas Biopharmaceuticals Extend Their Collaborative Development Of Biosimilars To Include Pegfilgrastim

Apotex Inc. of Canada and Intas Biopharmaceuticals Limited (IBPL) of India have extended their business agreement to develop a biosimilar version of pegfilgrastim, a protein that is used to treat neut...

Gallus BioPharmaceuticals: Mark Bamforth talks about saving jobs, local support and the importance of finding the right investment partners.

In this episode of PharmaTelevision News Review, Fintan Walton talks to Mark Bamforth, President and CEO of Gallus BioPharmaceuticals.

Comparing Sinovac Biotech (SVA) and Its Competitors

Sinovac Biotech is one of 45 public companies in the "Biopharmaceuticals" industry, but how does it weigh in compared to its competitors? We will compare Sinovac Biotech to similar businesses based on...

Drugs and Medications [1 Associated Drugs and Medications listed on BioPortfolio]

Thrombin human [Ethicon, Inc]

These highlights do not include all the information needed to use EVITHROM safely and effectively. See full prescribing information for EVITHROM.EVITHROM, Thrombin, Topical (Human)For Topical Use Only...

PubMed Articles [29 Associated PubMed Articles listed on BioPortfolio]

The importance of biosimilars medicines for private and statutory health insurance.

Patented biopharmaceuticals generate huge costs for private and statutory health insurance. Exactly ten years ago, off-patent biopharmaceuticals, also referred to as 'biosimilars medicines', became av...

A comprehensive screening platform for aerosolizable protein formulations for intranasal and pulmonary drug delivery.

Aerosolized administration of biopharmaceuticals to the airways is a promising route for nasal and pulmonary drug delivery, but - in contrast to small molecules - little is known about the effects of ...

Therapeutic miRNA and siRNA: Moving from Bench to Clinic as Next Generation Medicine.

In the past few years, therapeutic microRNA (miRNA) and small interfering RNA (siRNA) are some of the most important biopharmaceuticals that are in commercial space as future medicines. This review su...

Response to Tetanus and Pneumococcal Vaccination Following Administration of Ixekizumab in Healthy Participants.

Ixekizumab (IXE) is an interleukin (IL)-17A antagonist approved for the treatment of adults with moderate-to-severe psoriasis.

Optimization of Capillary Zone Electrophoresis for Charge Heterogeneity testing of Biopharmaceuticals using Enhanced Method Development Principles.

Capillary zone electrophoresis is a well-established technique for charge heterogeneity testing of biopharmaceuticals 1. It is based on the differences between the ratios of net charge and hydrodynami...

Clinical Trials [3 Associated Clinical Trials listed on BioPortfolio]

Pilot Study Evaluating the Safety and Potential Trends in Efficacy of Adhexil

The objective is to evaluate the safety and initial efficacy of the Omrix Anti-Adhesion (AA) kit, Adhexil™ in preventing and/or reducing post-operative adhesions in patients undergoing s...

Nicotine Vaccination and Nicotinic Receptor Occupancy

This is a molecular imaging research study designed to examine how much nicotine gets into the brain before and after vaccination with NicVAX, a nicotine vaccine developed by Nabi Biopharm...

A Phase III Clinical Trial of a Haemophilus Influenzae Type b (Hib) Conjugate Vaccine

Haemophilus influenza type b (Hib) remains a serious global health threat associated with high mortality and morbidity in young children. In China, The overall impact of Hib-related infect...

Companies [185 Associated Companies listed on BioPortfolio]

Itero Biopharmaceuticals, Inc.

Itero Biopharmaceuticals, Inc. is a specialty biopharmaceutical company focused on the development and commercialization of protein therapeutics that offer significant clinical an...

Bechtel Group Biopharmaceuticals Production

Design, construction, and validation of facilities for production of human biopharmaceuticals utilizing either fermentation or cell culture, facilities maintenance & operation for the virtual organiza...

BioRexis Pharmaceutical Corporation

BioRexis™ develops and produces novel biopharmaceuticals with superior pharmacology using efficient manufacturing systems. Many biopharmaceuticals face difficulties in development and commercializat...

Omrix Biopharmaceuticals

We aim to develop novel technologies to provide safer and more effective options to patients in areas with substantial unmet medical needs, particularly in the areas of biosurgical and passive immunot...

Inspiration Biopharmaceuticals, Inc.

Inspiration Biopharmaceuticals is dedicated exclusively to developing treatments for hemophilia, with a primary mission to broaden access to care, including prophylactic therapy, and improve the treat...

More Information about "Omrix Biopharmaceuticals" on BioPortfolio

We have published hundreds of Omrix Biopharmaceuticals news stories on BioPortfolio along with dozens of Omrix Biopharmaceuticals Clinical Trials and PubMed Articles about Omrix Biopharmaceuticals for you to read. In addition to the medical data, news and clinical trials, BioPortfolio also has a large collection of Omrix Biopharmaceuticals Companies in our database. You can also find out about relevant Omrix Biopharmaceuticals Drugs and Medications on this site too.

Quick Search


Relevant Topics

Within medicine, nutrition (the study of food and the effect of its components on the body) has many different roles. Appropriate nutrition can help prevent certain diseases, or treat others. In critically ill patients, artificial feeding by tubes need t...

The Top 100 Pharmaceutical Companies
Top 10 biotech and pharmaceutical companies worldwide based on market value in 2015 2015 ranking of the global top 10 biotech and pharmaceutical companies based on revenue (in billion U.S. dollars) Johnson & Johnson, U.S. 74...

Corporate Database Quicklinks

Searches Linking to this Company Record